Gluco-incretins regulate beta-cell glucose competence by epigenetic silencing of Fxyd3 expression.

Gluco-incretins regulate beta-cell glucose competence by epigenetic silencing of Fxyd3 expression.

<h4>Background/aims</h4>Gluco-incretin hormones increase the glucose competence of pancreatic beta-cells by incompletely characterized mechanisms.<h4>Methods</h4>We searched for genes that were differentially expressed in islets from control and Glp1r-/-; Gipr-/- (dKO) mice,...

Full description

Bibliographic Details
Main Authors:	David Vallois, Guy Niederhäuser, Mark Ibberson, Vini Nagaraj, Lorella Marselli, Piero Marchetti, Jean-Yves Chatton, Bernard Thorens
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25058609/pdf/?tool=EBI

Similar Items

Correction: Gluco-Incretins Regulate Beta-Cell Glucose Competence by Epigenetic Silencing of Fxyd3 Expression
by: The Staff
Published: (2014-01-01)

Correction: Gluco-Incretins Regulate Beta-Cell Glucose Competence by Epigenetic Silencing of Expression.
Published: (2014-01-01)

Impaired AQP2 trafficking in Fxyd1 knockout mice: A role for FXYD1 in regulated vesicular transport.
by: Elena Arystarkhova, et al.
Published: (2017-01-01)

FXYD3: A Promising Biomarker for Urothelial Carcinoma
by: ZhongFa Zhang, et al.
Published: (2011-02-01)

Expression and Significance of FXYD-3 Protein in Gastric Adenocarcinoma
by: Zhen-Long Zhu, et al.
Published: (2010-01-01)

Inflammation and Incretins
by: Amitabh Hatwal
Published: (2012-01-01)

FXYD5: Na+/ K+-ATPase Regulator in Health and Disease.
by: Irina eLubarski Gotliv
Published: (2016-03-01)

FXYD6 overexpression in HBV-related hepatocellular carcinoma with cirrhosis
by: Chen Xiongfei, et al.
Published: (2020-04-01)

Incretin receptor null mice reveal key role of GLP-1 but not GIP in pancreatic beta cell adaptation to pregnancy.
by: R Charlotte Moffett, et al.
Published: (2014-01-01)

Metabolic response of Insulinoma 1E cells to glucose stimulation studied by fluorescence lifetime imaging
by: Gianmarco Ferri, et al.
Published: (2020-07-01)

FXYD5 Is an Essential Mediator of the Inflammatory Response during Lung Injury
by: Patricia L. Brazee, et al.
Published: (2017-06-01)

Structure and properties of totally synthetic galacto- and gluco-cerebrosides
by: Kumkum Saxena, et al.
Published: (1999-05-01)

Pleiotropic effects of incretins
by: Vishal Gupta
Published: (2012-01-01)

The Selection of FXYD2 Targeting Aptamers for Detection of Ovarian Clear Cell Carcinoma
by: Jui-YuChen, et al.
Published: (2018)

Overexpression of FXYD-3 Is Involved in the Tumorigenesis and Development of Esophageal Squamous Cell Carcinoma
by: Zhen-Long Zhu, et al.
Published: (2013-01-01)

FXYD proteins, the regulator of Na+, K+-ATPase of the euryhaline teleost, Tetraodon nigroviridis
by: Pei-Jen Wang, et al.
Published: (2010)

Effect of differentiation, de novo innervation, and electrical pulse stimulation on mRNA and protein expression of Na+,K+-ATPase, FXYD1, and FXYD5 in cultured human skeletal muscle cells.
by: Vid Jan, et al.
Published: (2021-01-01)

Role of fasting duration and weekday in incretin and glucose regulation
by: Kim K B Clemmensen, et al.
Published: (2020-04-01)

Gluco-metabolic effects of oral and intravenous alcohol administration in men
by: Amalie R Lanng, et al.
Published: (2019-10-01)

Manufacture of gluco-oligosaccharide prebiotic by Gluconobacter oxydans NCIMB 4943
by: Santad Wichienchot, et al.
Published: (2010-01-01)

Separation of gluco- and galactocerebrosides by means of borate thin-layer chromatography
by: Edward L. Kean
Published: (1966-05-01)

Nickel and Epigenetic Gene Silencing
by: Hong Sun, et al.
Published: (2013-10-01)

Epigenetic silencing in transgenic plants
by: Sarma eRajeev Kumar, et al.
Published: (2015-09-01)

Stimulation of incretin secreting cells
by: Ramona Pais, et al.
Published: (2016-02-01)

The Origin and Understanding of the Incretin Concept
by: Jens F. Rehfeld
Published: (2018-07-01)

Incretins in patients with rheumatoid arthritis
by: Beatriz Tejera-Segura, et al.
Published: (2017-10-01)

Incretin hormones as immunomodulators of atherosclerosis
by: Nuria eAlonso, et al.
Published: (2012-09-01)

Understanding the Cardiovascular Effects of Incretin
by: Ji Sung Yoon, et al.
Published: (2011-10-01)

Bariatric Surgery: It's Not Just Incretins!
by: Ferraz-Bannitz, R., et al.
Published: (2022)

Breaking an epigenetic chromatin switch: curious features of hysteresis in Saccharomyces cerevisiae telomeric silencing.
by: Vijayalakshmi H Nagaraj, et al.
Published: (2014-01-01)

Pancreatic Beta Cell Identity in Humans and the Role of Type 2 Diabetes
by: Piero Marchetti, et al.
Published: (2017-05-01)

Structural and functional investigation of Na+, K+-ATPase regulators : FXYD proteins and cardiac glycosides
by: Whittaker, Christopher Andrew Paul
Published: (2011)

Investigation of the role of FXYD2 gene in functional recovery of mice with spinal cord injury
by: Li-Yun Ding, et al.
Published: (2007)

Expression and potential role of FXYD proteins in the saltwater model brackish medaka, Oryzias dancena
by: Wen-Kai Yang, et al.
Published: (2013)

Preparation and Properties of New Co-Crystals of Ibandronate with Gluco- or Galactopyranoside Derivatives
by: Jiri Dohnal, et al.
Published: (2010-12-01)

The degradation of methyl beta-D-gluco-pyranoside by oxygen in alkaline solution
by: McCloskey, John T.
Published: (2005)

vMonGluco - sistema de monitoramento contínuo de glicose.
by: Alexandre Murakami
Published: (2007)

vMonGluco - sistema de monitoramento contínuo de glicose.
by: Murakami, Alexandre
Published: (2007)

Durable CRISPR-Based Epigenetic Silencing
by: Muneaki Nakamura, et al.
Published: (2021-01-01)

Epigenetic Silencing of DKK3 in Medulloblastoma
by: André Oberthuer, et al.
Published: (2013-04-01)